Diabetes in Control Publisher Steve Freed and Dr. Richard Bergman discuss his ADA presentations — the relationship between diabetes and altitude, and the role of kidneys in diabetes research. Steve also asks why the degredation of insulin in the liver is important in the pathogenesis of diabetes. Dr. Bergman is the founder and director of Diabetes and Obesity Research Institute, Biomedical Sciences at Cedars-Sinai in Los Angeles. He introduced the use of engineering principles to understand the pathogenesis of diabetes.
Read More »Treatment Preference
Of the new medications for type 2 patients, which one do you prefer most for an overweight type 2 patient with an A1c of 8.5% after putting them on metformin? Follow the link to respond.
Read More »Question #812
A 59-year-old patient who was diagnosed with type 2 diabetes five years ago presents to your clinic for an appointment. He has a history of hypertension and dyslipidemia, both currently well controlled with medication. He has been taking metformin and a DPP-4 inhibitor. He tells you he is concerned about a sore on his foot that is taking a long time to heal. At today’s visit, his office A1C is 8.8%. After discussing his options, you decide to add basal insulin analogue detemir to his regimen. Compared to insulin NPH, what would you expect him to experience while taking detemir? Follow the link to answer.
Read More »Where Do SGLT-2 Inhibitors Fit in Diabetes Care?
Various T2 factors create need for multiple treatment options.
Read More »Insulin Secretion Restored At Diagnosis of Type 1 With Tight Control
New study focuses on isolated islets of Langerhans.
Read More »Risks and Benefits of GLP-1s
Systemic review, network meta-analysis found treatment resulted in greatest reductions in HbA1c, fasting blood glucose, and body weight.
Read More »Controlled Type 2 Patients Being Over Treated
Nearly half of patients with stable A1c, who do not use insulin, found to be unnecessarily tested three to four times a year.
Read More »Victoza Vs. SGLT-2 inhibitor for Better BG Control
Safety, efficacy of these new classes of diabetic medication require more detailed investigation.
Read More »Structured Personal Diabetes Care Reduced Mortality Rates in Women, Not Men
New study showed women accept disease, implement disease management more easily.
Read More »Diabetes for Cardiologists Part 1
In this week's Homerun Slides, we begin a new series on the role of anti-diabetes medications in reducing cardiovascular risk and outcomes in diabetes patients.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.